[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat Tıp Dergisi
2008, Cilt 13, Sayı 3, Sayfa(lar) 188-190
[ Turkish ] [ Tam Metin ] [ PDF ]
Status Epilepticus: Etiology, Clinical Features, Treatment and Prognosis
Zeynep BİNGÖL, Bülent MÜNGEN, Muhammed Said BERİLGEN, Adalet RIKANOĞLU, Seda ÖZEL, Fidan SÜRGÜN
Fırat Üniversitesi Tıp Fakültesi, Nöroloji Anabilim Dalı, ELAZIĞ

Objectives: Our aim is to investigate the patients who were followed up and treated in our neurology clinic and intensive care unit between 1996 and 2007 in terms of etiologic cause, clinical features, treatmentant and prognosis.

Materials and Methods: 83 patients consisting of 47 males and 36 females (whose average age is 38 ± 19.7, minimum 14 years, maximum 87 years) and who were followed up between 1996 and 2007 have been included in this study.

Results: In our study group, the first three etiologic causes were found to be idiopathic epilepsy (42%), cerebrovascular disease (14.5%) and metabolic disorders (10.8%). Seizure types of status epilepticus (SE) were primary tonic-clonic seizure in 62 patients, complex partial seizure + secondary generalized tonic-clonic seizure in 7 patients, and focal motor seizure + secondary generalized tonic-clonic seizure in 14 patients. 70 of our patients were non-refractery SE, the rest were refractery SE. In the non-refractery group, intravenous benzodiazepine + diphenilhidantoin infusion were conducted as a treatment. In resistant cases, besides this treatment midazolam infusion, propofol infusion or valproate infusion were added to the treatment.

Conclusion: 16 of our patients died (mortality rate is 19.2%). Some of these patients died due to SE complications because SE couldn't be stopped. In other patients SE were stopped, however these patients died due to reasons related to the fundamental disease beneath. In mortality in SE, it was noted that the age of the patient, the etiologic cause beneath and the beginning time of SE treatment. ©2008, Firat University, Medical Faculty.


[ Turkish ] [ Tam Metin ] [ PDF ]
[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]